SMTL ID : 2uzl.2 (1 other biounit)

Crystal structure of human CDK2 complexed with a thiazolidinone inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-1-1-mer

Ligands

1 x C94: 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE(Non-covalent)

C94.1: 14 residues within 4Å: Chain A: I.10, G.13, A.31, K.33, F.80, E.81, F.82, L.83, H.84, Q.85, D.86, K.89, L.134, D.145 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.10, A:A.31, A:L.134, A:L.134 Hydrogen bonds: A:K.33, A:D.86, A:D.145, A:D.145, A:D.145 Water bridges: A:F.146

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Richardson, C.M. et al., Discovery of a Potent Cdk2 Inhibitor with a Novel Binding Mode, Using Virtual Screening and Initial, Structure-Guided Lead Scoping. Bioorg.Med.Chem.Lett. (2007)

Release Date

2007-06-26

Peptides

CELL DIVISION PROTEIN KINASE 2: A
CYCLIN A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

CELL DIVISION PROTEIN KINASE 2

CYCLIN A2

Related Entries With Identical Sequence